![]() |
|
|
Vol. 294, Issue 3, 916-922, September 2000
Department of Environmental Health, University of Washington,
Seattle, Washington
Oxidative biotransformation, coupled with genetic variability in enzyme
expression, has been the focus of hypotheses interrelating environmental and genetic factors in the etiology of central nervous system disease processes. Chemical modulation of cerebral
cytochrome P450 (P450) monooxygenase expression character may be an
important determinant of in situ metabolism, neuroendocrine
homeostasis, and/or central nervous system toxicity resulting from
exposure to neuroactive drugs and xenobiotic substances. To examine the capacity of the rat brain to undergo phenobarbital (PB)-mediated induction, we developed reverse transcription-polymerase chain reaction
methods and evaluated the effects of several PB-like inducers on P450
and microsomal epoxide hydrolase gene expression. Animals treated i.p.
with four daily doses of PB demonstrated markedly induced levels of
CYP2B1, CYP2B2, and CYP3A1 mRNA in the striatum and cerebellum. In
contrast, 1 or 2 days of PB treatment resulted in unchanged or even
slightly decreased levels of CYP2B1 and CYP2B2 in the brain, although
the latter treatments produced marked induction of the corresponding
genes in the liver. Only slight increases in epoxide hydrolase RNA
levels resulted in brains of PB-treated animals. Substantial
activation of cerebral CYP2B1, CYP2B2, and CYP3A1 mRNA levels also
resulted when animals were treated with the neuroactive drugs
diphenylhydantoin and amitryptiline, and with the potential PB-like
xenobiotic inducers trans-stilbene oxide and diallyl
sulfide, whereas dichlorodiphenyltrichloroethane was less efficacious.
Although the time course of the induction response is delayed in brain
relative to that required for the liver, these results clearly
establish that brain P450s are markedly PB inducible.
This article has been cited by other articles:
![]() |
A. L. Slitt, N. J. Cherrington, C. D. Fisher, M. Negishi, and C. D. Klaassen INDUCTION OF GENES FOR METABOLISM AND TRANSPORT BY TRANS-STILBENE OXIDE IN LIVERS OF SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS Drug Metab. Dispos., July 1, 2006; 34(7): 1190 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Slitt, N. J. Cherrington, M. Z. Dieter, L. M. Aleksunes, G. L. Scheffer, W. Huang, D. D. Moore, and C. D. Klaassen trans-Stilbene Oxide Induces Expression of Genes Involved in Metabolism and Transport in Mouse Liver via CAR and Nrf2 Transcription Factors Mol. Pharmacol., May 1, 2006; 69(5): 1554 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Ueng, C.-C. Hung, M.-L. Kuo, P.-K. Chan, S.-H. Hu, P.-C. Yang, and L. W. Chang Induction of Fibroblast Growth Factor-9 and Interleukin-1{alpha} Gene Expression by Motorcycle Exhaust Particulate Extracts and Benzo(a)pyrene in Human Lung Adenocarcinoma Cells Toxicol. Sci., October 1, 2005; 87(2): 483 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qu, J. A. Bradbury, C.-C. Tsao, R. Maronpot, G. J. Harry, C. E. Parker, L. S. Davis, M. D. Breyer, M. P. Waalkes, J. R. Falck, et al. Cytochrome P450 CYP2J9, a New Mouse Arachidonic Acid omega -1 Hydroxylase Predominantly Expressed in Brain J. Biol. Chem., June 29, 2001; 276(27): 25467 - 25479. [Abstract] [Full Text] [PDF] |
||||